Paracetamol Comp. (Paracetamol, Codeine Phosphate Hemihydrate)

Paracetamol reduces pain and fever by inhibiting central cyclooxygenase enzymes, lowering prostaglandin production. Codeine phosphate hemihydrate is a pro‑drug converted to morphine, which activates μ‑opioid receptors in the brain and spinal cord, producing analgesia and cough suppression.

The dose of Paracetamol Comp. is determined by the prescribing clinician based on the patient’s age, weight, pain severity, and clinical condition. Patients should follow the prescriber’s instructions and never adjust the dose without medical advice.

Safety in pregnancy and lactation has not been fully established. The product should be used only if the potential benefit justifies the potential risk to the fetus or infant, and only under the guidance of a qualified health professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with paracetamol alone, the addition of codeine provides stronger analgesia and can address moderate pain that may not respond to non‑opioid therapy. Compared with stronger opioids, the combination offers a lower risk of severe respiratory depression but still requires careful monitoring.

Store Paracetamol Comp. at ambient temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep out of reach of children and do not use after the expiry date printed on the label.

The product is taken orally, usually with a glass of water. It may be taken with or without food, but if gastrointestinal upset occurs, it can be taken with a light meal. Swallow tablets whole; do not crush or chew unless instructed by a healthcare professional.

Serious risks include respiratory depression, especially when combined with other CNS depressants, severe allergic reactions, hepatotoxicity from excessive paracetamol exposure, and the potential for dependence or abuse associated with codeine. Immediate medical attention is required if any of these occur.

The product should be avoided in individuals with known hypersensitivity to paracetamol or codeine, severe respiratory depression, uncontrolled liver disease, or those taking MAO inhibitors. It is also contraindicated in children under the age specified by local regulations unless prescribed by a physician.